Industry NewsCN Bio and Altis Biosystems partner to develop next-generation human gut/liver in vitro model for advanced ADME studies
Product NewsCN Bio extends microphysiological system portfolio with PhysioMimix single-organ higher throughput system
Industry NewsThe FDA further expands collaboration with CN Bio to evaluate the PhysioMimix multi-organ microphysiological system
Industry NewsCN Bio licenses human gut microbiome modelling tool from MIT and Northeastern University
Industry NewsLonza and CN Bio announce distribution agreement providing prevalidated hepatocytes for use on innovative organ-on-a-chip range
Industry NewsCN Bio’s PhysioMimix adopted by King’s College London to investigate chronic liver disease
Industry NewsCN Bio FDA collaboration expanded to investigate lung-on-a-chip model for inhaled drug evaluation applications
Industry NewsCN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research
Industry NewsCN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients
Industry NewsCN Bio and Cambridge University identify novel regulatory pathway driving Non-Alcoholic Steatohepatitis
